Search Results - "., M. Semreen"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research by Ahmed, Munazza, Semreen, Ahlam M, El-Huneidi, Waseem, Bustanji, Yasser, Abu-Gharbieh, Eman, Alqudah, Mohammad A Y, Alhusban, Ahmed, Shara, Mohd, Abuhelwa, Ahmad Y, Soares, Nelson C, Semreen, Mohammad H, Alzoubi, Karem H

    “…Glioblastoma (GB) is a primary malignancy of the central nervous system that is classified by the WHO as a grade IV astrocytoma. Despite decades of research,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel by Ahmed, Munazza, Semreen, Ahlam M, Giddey, Alexander D, Ramadan, Wafaa S, El-Awady, Raafat, Soares, Nelson C, El-Huneidi, Waseem, Bustanji, Yasser, Alqudah, Mohammad A Y, Alzoubi, Karem H, Semreen, Mohammad H

    Published in Annals of medicine (Helsinki) (2023)
    “…Glioblastoma (GBM) is a primary malignancy of the central nervous system and is classified as a grade IV astrocytoma by the World Health Organization (WHO)…”
    Get full text
    Journal Article
  4. 4

    Multi-omics analysis revealed significant metabolic changes in brain cancer cells treated with paclitaxel and/or topotecan by Semreen, Ahlam M., Alsoud, Leen Oyoun, Semreen, Mohammad H., Ahmed, Munazza, Al-Hroub, Hamza M., El-Awady, Raafat, Ramadan, Wafaa S., Abuhelwa, Ahmad, Bustanji, Yasser, Soares, Nelson C., Alzoubi, Karem H.

    Published in Heliyon (15-11-2024)
    “…Glioblastoma (GBM) stands as the most common primary malignant brain tumor. Despite the best standard therapies, GBM survivors have a brief survival time,…”
    Get full text
    Journal Article
  5. 5

    Evaluation of imidazo[2,1–b]thiazole-based anticancer agents in one decade (2011–2020): Current status and future prospects by Sbenati, Rawan M., Semreen, Mohammad H., Semreen, Ahlam M., Shehata, Mahmoud K., Alsaghir, Fai M., El-Gamal, Mohammed I.

    Published in Bioorganic & medicinal chemistry (01-01-2021)
    “…[Display omitted] •Recent reports on imidazothiazole-based anticancer agents have been reviewed.•We focused on articles published in the last decade…”
    Get full text
    Journal Article
  6. 6

    Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design by Ficarra, R, Calabrò, M.L, Cutroneo, P, Tommasini, S, Melardi, S, Semreen, M, Furlanetto, S, Ficarra, P, Altavilla, G

    “…A rapid and sensitive RP-HPLC method with UV detection for routine control of oxaliplatin in a pharmaceutical formulation (Eloxatin®) was developed…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation by Ficarra, R, Ficarra, P, Tommasini, S, Melardi, S, Calabrò, M.L, Furlanetto, S, Semreen, M

    “…A reversed-phase high-performance liquid chromatographic (HPLC) method was developed and validated for estimation of zafirlukast in a pharmaceutical…”
    Get full text
    Journal Article Conference Proceeding
  8. 8
  9. 9
  10. 10

    Superdisintegrants for solid dispersion: To produce rapidly disintegrating tenoxicam tablets via camphor sublimation by ALY, Adel M, SEMREEN, M, QATO, Mazen K

    Published in Pharmaceutical Technology (2005)
    “…The authors examined the effects of three super-disintegrands (Kollidon CL, Ac-Di-sol, and Primojel) on the dissolution and absorption of tenoxicam from…”
    Get full text
    Magazine Article Trade Publication Article